openPR Logo
Press release

Radiodermatitis Market Research Report | Forecast 2024

06-14-2017 12:53 AM CET | Health & Medicine

Press release from: Transparency Market Research

The global radiodermatitis market is consolidated, with the top five players accounting for a share of just over 47% in 2015. These are 3M Healthcare, Smith & Nephew plc, Molnlycke Health Care, Acelity, and Convatec, Inc. Transparency Market Research finds that success in the radiodermatitis market is dependent on the ability of pharma and medical device companies to develop innovative products that can address unmet consumer needs and also help differentiate the company from its competitors.

Stratpharma AG, for instance, launched the StrateXRT in 2016 – a class 1 wound dressing listed with the US FDA and a medical device registered with the European CE mark. This novel and flexible wound dressing is designed for the prevention as well as treatment of radiation dermatitis.

View Report @ http://www.transparencymarketresearch.com/radiodermatitis-market.html

The opportunity in the global radiodermatitis market was worth US$299.6 mn in 2015 and, registering a CAGR of 3.9% from 2016 to 2024, will be worth US$421.5 mn by 2024.

Multichannel Distribution an Effective Approach in Radiodermatitis Market

Topical agents are the most preferred and prescribed products in the radiodermatitis market. Accounting for a share of just under 70% in 2015, the revenue generated by this segment is projected to cross US$300 mn by 2024. The topical segment is anticipated to register a 4.2% CAGR during the forecast period, higher than any other product segment. The oral medication segment holds a negligible share in the global radiodermatitis market and is anticipated to further lose market share by 2024.

By distribution channel, the retail pharmacy store segment led the radiodermatitis market in 2015, closely followed by the online store segment. TMR finds that on the whole, a multichannel approach works increasingly well in the radiodermatitis market owing to the nature of the onset of radiodermatitis, which can occur either during or after radiation therapy.

Geographically, Asia Pacific led the global radiodermatitis market in 2015, accounting for a share of over 45% that year. This region, along with Latin America, are both anticipated to register a CAGR of 4.0% from 2016 to 2024, emerging as two of the most lucrative markets for radiodermatitis treatment.

Innovation in Product Offerings a Key Growth Driver for Radiodermatitis Market

The World Health Organization states that the number of new cancer cases worldwide is projected to rise from 14 million per year in 2012 to 22 million by 2032. Cancer patients are more likely to develop radiation-induced dermatitis owing to frequent radiation treatments. “Unhealthy lifestyle factors, such as obesity and smoking, aggravate the rate of cancer incidence and this will further boost the prevalence as well as market for radiodermatitis,” the author of the study finds.

The global market for radiodermatitis is also fueled by the rising innovation in product offerings. “Companies have been increasingly focused on churning out innovative products in order to fill the gap of unmet needs in the radiodermatitis market,” the lead analyst observes. The painful condition of the patient and poor quality of life has been compelling patients to opt for as many new and different radiodermatitis treatment options as possible and this acts as a driving factor for drug and device manufacturing companies.

This review is based on the findings of a TMR report titled “Radiodermatitis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024.”

Get accurate market forecast and analysis on the Radiodermatitis Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2157

Global Radiodermatitis Market, by Product

Topical
Corticosteroids
Hydrophilic Creams
Others (topical antibiotics)
Oral Medication
Corticosteroids
Other (oral analgesics, antibiotics, etc.)
Dressings
Hydrogel
Hydrocolloid
No Sting Barrier Film
Honey Impregnated Gauze
Silicone Coated Dressing
Others (GM-CSF gauze, silver leaf dressing, etc.)
Global Radiodermatitis Market, by Distribution Channel

Hospital Pharmacy
Retail Pharmacy Store
Online Store
Global Radiodermatitis Market, by Geography

North America
U.S.
Canada
Asia Pacific
China
Japan
Rest of APAC
Europe
U.K.
Germany
Rest of Europe
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
South Africa
Rest of Middle East & Africa

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiodermatitis Market Research Report | Forecast 2024 here

News-ID: 577505 • Views: 380

More Releases from Transparency Market Research

Meningitis Diagnostic Testing Market Outlook, Trend, Growth and Share Estimation …
Meningitis Diagnostic Testing Market: Overview The global meningitis diagnostic testing market was valued over US$ 105.5 Mn in 2016 and is projected to register cumulative annual growth rate (CAGR) of over 3.0% from 2017 to 2025, according to a new report published by Transparency Market Research (TMR) titled "Meningitis Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017-2025". The report suggests that rising demand for innovative
Metformin Hydrochloride API Market to Expand at a CAGR of ~5% from 2021 to 2031
Metformin Hydrochloride API Market: Introduction According to the report, the global metformin hydrochloride API market was valued at ~US$ 300 Mn in 2020 and is projected to expand at a CAGR of ~5% from 2021 to 2031. Metformin hydrochloride is primarily used in the treatment of diabetes. The prevalence of diabetes is expected to increase across the world due to change in lifestyle and factors such as malnutrition and genetic mutations.
Telehealth Market to Reach the Value of US$ 15 Bn by the End of 2028
Telehealth Market: Introduction According to the report, the global telehealth market was valued at US$ 7.8 Bn in 2020 and is projected to expand at a CAGR of 7% from 2021 to 2028. The global telehealth market has witnessed strong growth in the past few years. Telehealth is no longer an option, but a necessity due to the increasing dangers of COVID-19. Read Report Overview - https://www.transparencymarketresearch.com/telehealth-market.html The crisis presents an opportunity
Lyme Disease Treatment Market Growth Trends, Current Demand, and Development Rep …
Lyme Disease Treatment Market: Introduction According to the report, the global Lyme disease treatment market was valued at US$ 1.58 Bn in 2020 and is projected to expand at a CAGR of ~6% from 2021 to 2031. Increase in pet ownership, surge in awareness & adoption of veterinary care, and rise in healthcare expenditure on animals are anticipated to drive the global Lyme disease treatment market from 2021 to 2031.North America

All 5 Releases


More Releases for Radiodermatitis

Radiodermatitis - Pipeline Review and Insight, H1 2018
Market Research HUB has added a new report titled "Radiodermatitis - Pipeline Review, H1 2018" to it's huge database of pharmaceutical reports. This Report provides an overview of the Radiodermatitis (Toxicology) pipeline landscape. Radiodermatitis is an inflammation of the skin caused by radiation. Several factors can be attributed to the varying response of patients' skin to radiation therapy such as treatment-related factors such as individual fraction size, type of energy,
Global Radiodermatitis Market Assessment and Key Insights Analyzed till 2024
Market Research Report Search Engine (MRRSE) recently announced the addition of a new research study to its comprehensive collection of research reports. The research report, titled “Radiodermatitis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024” offers a detailed analysis of the market providing insights into the market dynamics that are expected to influence the overall market positively in the next few years. Furthermore, the
Radiodermatitis Market Insights and Analysis for Period 2016 - 2024
The global radiodermatitis market is consolidated, with the top five players accounting for a share of just over 47% in 2015. These are 3M Healthcare, Smith & Nephew plc, Molnlycke Health Care, Acelity, and Convatec, Inc. Transparency Market Research finds that success in the radiodermatitis market is dependent on the ability of pharma and medical device companies to develop innovative products that can address unmet consumer needs and also help
Radiodermatitis Market
Radiodermatitis Market size is projected to experience significant growth from 2017 to 2024. Radiodermatitis market size should witness significant growth due to rising incidences of cancer across the globe. As per WHO, in 2012, 14 million new cancer cases were diagnosed and the number is envisaged to reach 21 million by 2030. Cancer patients are prone to develop radiation-induced skin reactions or radiation dermatitis which impacts the physical functioning and
Global Radiodermatitis Sales Market Report 2017
The Global Radiodermatitis Sales Market Report 2017 is a professional and in-depth study on the current state of the Radiodermatitis industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Radiodermatitis market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report
Radiodermatitis Market: Topical Agents to Remain Most Widely Used Product Type f …
The global radiodermatitis market has been witnessing a significant progress over the last few years on the grounds of the rising prevalence of cancer and the growing uptake of radiation therapy for its treatment. Thanks to the increasing focus on product innovations and advancements in existing products, the market is also showing high potential for future growth. Over the coming years, the unmet medical needs of consumers in emerging regions is